Clicky

Ion Beam Applications SA(IBAB)

Description: Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for advance research in ConformalFLASH. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.


Keywords: Cancer Medical Device Medical Imaging Treatment Of Cancer Radiation Medical Physics Physics Radiation Therapy Turnkey Solutions Tomography Radiobiology Radioactivity Ionizing Radiation And Services Proton Therapy Accelerator Physics Particle Accelerator University Of Pennsylvania Fabricates Ion Beam Applications Medical Imaging Quality Assurance Proton Therapy Systems

Home Page: www.iba-worldwide.com

3, Chemin du Cyclotron
Louvain-la-Neuve, 1348
Belgium
Phone: 32 1 047 58 11


Officers

Name Title
Mr. Pierre Mottet Chairman of The Board
Mr. Olivier Legrain CEO, Pres, MD & Exec. Director
Mr. Yves Jongen Founder, Chief Research Officer, MD & Exec. Director
Ms. Soumya Chandramouli Chief Financial Officer
Mr. Frederic Nolf Chief HR & Sustainability Officer
Olivier Lechien Corp. Communication Director
Mr. Matthias Dierl Ph.D. Chief Medical Physicist of Radiation Therapy
Marc Van der Burght Exec. VP of Proton Therapy Installation

Exchange: BR

Country: BE

Currency: Euro (€)

Forward PE: 34.4828
Trailing PE: 128.5714
Price-to-Book MRQ: 4.6484
Price-to-Sales TTM: 1.313
IPO Date:
Fiscal Year End: December
Full Time Employees: 1668
Back to stocks